Ratiometric fluorescence sensor based on cholesterol oxidase-functionalized mesoporous silica nanoparticle@ZIF-8 core-shell nanocomposites for detection of cholesterol

Talanta ◽  
2018 ◽  
Vol 188 ◽  
pp. 708-713 ◽  
Author(s):  
Ke Wang ◽  
Hailong Ren ◽  
Nan Li ◽  
Xiaoyan Tan ◽  
Fuquan Dang
2020 ◽  
Vol 59 (14) ◽  
pp. 10275-10284 ◽  
Author(s):  
Marina Martínez-Carmona ◽  
Quy P. Ho ◽  
Jérémy Morand ◽  
Ana García ◽  
Enrique Ortega ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (39) ◽  
pp. 30640-30646 ◽  
Author(s):  
Yue Yan ◽  
Jie Fu ◽  
Xin Liu ◽  
Tianfu Wang ◽  
Xiuyang Lu

An intracellular acidity-triggered doxorubicin release from “click chemistry” functionalized mesoporous silica nanoparticle was demonstrated.


2012 ◽  
Vol 22 (17) ◽  
pp. 3576-3582 ◽  
Author(s):  
Susana Martin-Ortigosa ◽  
Justin S. Valenstein ◽  
Victor S.-Y. Lin ◽  
Brian G. Trewyn ◽  
Kan Wang

2020 ◽  
Vol 20 (12) ◽  
pp. 7362-7368
Author(s):  
Yongju He ◽  
Hui Xu ◽  
Shuquan Liang

A defect-related luminescent mesoporous silica nanoparticle (DLMSN) with simultaneous excellent luminescence, high drug loading efficiency and release capacity was prepared upon calcination of 3-aminopropyltriethoxysilane (APTES)-functionalized mesoporous silica nanoparticle (AP-MSN) under a relatively moderate temperature. Under ultraviolet excitation at 365 nm, DLMSN exhibited intense white-blue emission with a range of 400–500 nm, which was inferred to originate from the effective carbon or nitrogen defect in the particle causing by APTES calcination. Additionally, the luminescence intensity of DLMSN was significantly affected by APTES concentration and calcination temperature during the preparation procedure. Within all the tested values, the maximum luminescence intensity was achieved when APTES concentration and calcination temperature were 0.851 mmol and 300 °C, respectively. The drug storage and release tests demonstrated that DLMSN had efficient drug storage and good pH-dependent release for ibuprofen (IBU). Interestingly, ibuprofen-loaded DLMSN (IBU@DLMSN) still exhibit an intense luminescence with an emission peak at around 410 nm under 365 nm excitation, which gradually increased with the sustained release of IBU from IBU@DLMSN. These results suggest that the as-prepared DLMSN may have potential as a detectable nanocarrier in the drug delivery field.


2016 ◽  
Vol 13 (8) ◽  
pp. 2647-2660 ◽  
Author(s):  
Raymond Ebabe Elle ◽  
Saher Rahmani ◽  
Céline Lauret ◽  
Marion Morena ◽  
Luc Philippe Régis Bidel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document